Elephants and Tea - December 2022 - 26

Conversation PATIENTS FIRST
The Heart and
Soul of Servier
HOW THIS PHARMACEUTICAL COMPANY PUTS PATIENTS FIRST
BY LISA ORR
the utmost treatment and care to improve
the potential for survival.
At Servier, a deep commitment to
patients is fundamental to their overall
culture. After speaking to three individuals
who are connected to Servier either
through advocacy efforts or through employment,
it is clear that Servier Pharmaceuticals
stands apart in their dedication
to their mission as well as their efforts
towards developing innovative treatments
to help patients with cancer. Hearing
directly from people who interact with
the organization in various capacities
truly brings their incredible care to life.
Through our conversations, remarkable
aspects of the organization's values and
mission stood out, proving even further
that Servier is in a class of its own.
A
26
s a growing leader in oncology, Servier Pharmaceuticals is committed to finding
solutions that will address today's challenges. As a privately held company,
Servier has the freedom to do what many other publicly traded pharmaceutical
companies can't: devote their energy toward putting patients and caregivers
first. The company's oncology portfolio of innovative medicines is designed
to bring more life-saving treatments to a greater number of patients across the
entire spectrum of disease and in a variety of tumor types. Currently, they have
medicines approved that impact the adolescent and young adult acute lymphoblastic
leukemia (ALL) community. They also have a medicine approved to treat
adult patients with acute myeloid leukemia (AML) and cholangiocarcinoma (CCA). They
have also accelerated their investment in hard-to-treat cancers, with more than 50% of
research and development dedicated to oncology. Servier's goal is to serve patients with
ELEPHANTSANDTEA.COM
DECEMBER 2022
Servier's dedication goes beyond
the typical day-to-day. Their heroic
efforts to provide treatment to
patients is unmatched.
Whether it is chartering private planes to
ensure medications make it to their final
destination on time, or making personal
deliveries when mother nature adds an
obstacle like hurricanes or winter storms,
Servier stops at nothing to make sure that
patients are getting the therapies they
need, when they need them. " They always
do whatever they can. Their commitment
is pretty amazing... I don't know of any
other company that would do what they
do, " said Ruth Hoffman, CEO of the American
Childhood Cancer Organization. She
THIS ARTICLE IS
BROUGHT TO YOU BY
http://www.ELEPHANTSANDTEA.COM
Elephants and Tea - December 2022

Table of Contents for the Digital Edition of Elephants and Tea - December 2022
